Clinical trials in Villenave-d'Ornon

Clinical investigations focusing on advanced non-small cell lung cancer treatment approaches, specifically targeting patients with genetic mutations.

• Targeted Therapy Resistance
• Combination Treatment Strategies
• Genetic Mutation Analysis

Research explores innovative therapeutic combinations including platinum-based chemotherapy and immunotherapy agents for patients who have progressed after initial targeted treatments.

Studies examining treatment responses in patients with specific genetic alterations including EGFR mutations, ALK rearrangements, and ROS1 fusions.

• Biomarker Analysis
• Personalized Treatment Approaches
• Response Assessment

The research aims to optimize treatment strategies for specific patient subgroups based on their molecular profiles.

Investigation of treatment effectiveness through evaluation of objective response rates in advanced lung cancer patients.

• Treatment Efficacy Assessment
• Patient Response Monitoring
• Therapeutic Combinations

Studies focus on determining optimal treatment sequences and combinations for improved patient outcomes.